Medical robotics company Stereotaxis is acquiring France-based Robocath for up to $45 million, bringing together two complementary approaches to robotic catheter procedures..
Stereotaxis operates a magnetic navigation platform for catheter-based procedures. Robocath brings mechanical robotics expertise and its R-One+ system to the combination. The two technologies address different aspects of catheter control, and the combined IP portfolio is intended to support a broader procedural range across electrophysiology, interventional cardiology, and neurointerventions.
Robocath will operate as a Stereotaxis subsidiary with its existing team intact .The deal reflects ongoing consolidation in medical robotics, where companies are combining specialised platforms to chase broader procedural coverage and the scale required to navigate lengthy regulatory timelines. For Stereotaxis, adding mechanical robotics to its magnetic navigation platform fills a meaningful gap in its clinical offering.
